Ignyta, Inc. (1557421) SEC Filing 8-K Material Event for the period ending Thursday, August 17, 2017

Ignyta, Inc.

CIK: 1557421

View differences made from one to another to evaluate Ignyta, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Ignyta, Inc..


Assess how Ignyta, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Ignyta, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2017 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Ignyta, Inc. provided additional information to their SEC Filing as exhibits

CIK: 1557421
Form Type: 8-K Corporate News
Accession Number: 0001193125-17-262294
Submitted to the SEC: Fri Aug 18 2017 4:46:36 PM EST
Accepted by the SEC: Fri Aug 18 2017
Period: Thursday, August 17, 2017
Industry: Pharmaceutical Preparations
  1. Event for Officers
  2. Financial Exhibit

External Resources:

Bookmark the Permalink: